Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,48119,500 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Deciphering and targeting a non-genetic driver pathway in hepatocellular carcinoma
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

PROJECT SUMMARY Hepatocellular carcinoma (HCC) accounts for nearly 31,000 deaths annually in the United States alone. Factors that epigenetically silence an HCC tumor suppressor ge...

$4.03M
USD
Active NON-SBIR/STTR RPGS
Mapping the regulatory landscape of RNA binding proteins and their causal roles in tumorigenesis and patient survival
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2027

Summary Our preliminary results support a prominent role for dysregulation of RNA binding proteins (RBPs) in cancer progression. In fact, our analysis of the cancer genome atlas (T...

$3.38M
USD
Completed NON-SBIR/STTR RPGS
Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2021 – 2026

CRC is the third leading cause of tumor-related deaths attributed to vital organ metastasis. CRC patient survival is highly dependent on the cancer staging at the time of diagnosis...

$4.74M
USD
Completed NON-SBIR/STTR RPGS
Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2021 – 2026

CRC is the third leading cause of tumor-related deaths attributed to vital organ metastasis. CRC patient survival is highly dependent on the cancer staging at the time of diagnosis...

$2.14M
USD
Completed NON SBIR/STTR CONTRACTS
Frederick National Laboratory for Cancer Research (FNLCR) Center for SARS-CoV-2 Serological Sciences
NATIONAL CANCER INSTITUTE Leidos Biomedical Research, Inc United States 2021 – 2026

The purpose of the National Cancer Institute?s SARS-CoV-2 Serological Sciences Network (SeroNet) is to study the immune response to COVID-19 by developing and deploying serological...

$856.7K
USD
Completed NON SBIR/STTR CONTRACTS
Frederick National Laboratory for Cancer Research (FNLCR) Center for SARS-CoV-2 Serological Sciences
NATIONAL CANCER INSTITUTE Leidos Biomedical Research, Inc United States 2021 – 2026

The purpose of the National Cancer Institute’s SARS-CoV-2 Serological Sciences Network (SeroNet) is to study the immune response to COVID-19 by developing and deploying serological...

$579.1K
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of leukemogenesis in Down syndrome
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2021

PROJECT SUMMARY This is a competitive renewal of our NCI funded grant to study the contributions of trisomy 21 to hematologic malignancies.Children with Down syndrome (DS), who hav...

$3.84M
USD
Completed NON-SBIR/STTR RPGS
Quantitative top-down proteomics of human colorectal cancer cells and tumors
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2026

Project Summary It has been estimated that 145,600 people were diagnosed with colorectal cancer (CRC) and 51,020 deaths were predicted due to this disease in 2019 (https://seer.can...

$3.65M
USD
Completed OTHER RESEARCH-RELATED
Functional epigenomics of transgenic cellular immunotherapies for cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Cancer immunotherapy with T-cells expressing a transgenic T-cell receptor (TCR) can generate sustained clinical responses in a variety of malignancies. How...

$1.82M
USD
Completed NON-SBIR/STTR RPGS
MYC-regulated RNA Binding Protein Networks and Spliced Isoforms Driving Cancer
NATIONAL CANCER INSTITUTE Jackson Laboratory United States 2021 – 2026

SUMMARY Alternative RNA splicing is a key step in gene expression regulation and contributes to transcriptional diversity by selecting which transcript isoforms are produced in a s...

$5.86M
USD
Completed OTHER RESEARCH-RELATED
Functional epigenomics of transgenic cellular immunotherapies for cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Cancer immunotherapy with T-cells expressing a transgenic T-cell receptor (TCR) can generate sustained clinical responses in a variety of malignancies. How...

$1.82M
USD
Completed NON-SBIR/STTR RPGS
MYC-regulated RNA Binding Protein Networks and Spliced Isoforms Driving Cancer
NATIONAL CANCER INSTITUTE Jackson Laboratory United States 2021 – 2026

SUMMARY Alternative RNA splicing is a key step in gene expression regulation and contributes to transcriptional diversity by selecting which transcript isoforms are produced in a s...

$5.28M
USD
Completed OTHER RESEARCH-RELATED
Functional epigenomics of transgenic cellular immunotherapies for cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Cancer immunotherapy with T-cells expressing a transgenic T-cell receptor (TCR) can generate sustained clinical responses in a variety of malignancies. How...

$1.82M
USD
Completed NON-SBIR/STTR RPGS
Point of Care Diagnostic test for Molecular Subtyping of Breast Cancer (PoCBreCa Study)
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2021 – 2025

Point of Care Diagnostic test for Molecular Subtyping of Breast Cancer (PoCBreCa) Study Project Summary The incidence of breast cancer in low and middle-income countries (LMIC) is...

$1.77M
USD
Completed NON-SBIR/STTR RPGS
Quantitative top-down proteomics of human colorectal cancer cells and tumors
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2026

Project Summary It has been estimated that 145,600 people were diagnosed with colorectal cancer (CRC) and 51,020 deaths were predicted due to this disease in 2019 (https://seer.can...

$4.22M
USD
Completed NON-SBIR/STTR RPGS
Point of Care Diagnostic test for Molecular Subtyping of Breast Cancer (PoCBreCa Study)
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2021 – 2023

Point of Care Diagnostic test for Molecular Subtyping of Breast Cancer (PoCBreCa) Study Project Summary The incidence of breast cancer in low and middle-income countries (LMIC) is...

$2.29M
USD
Completed NON-SBIR/STTR RPGS
Quantitative top-down proteomics of human colorectal cancer cells and tumors
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2026

Project Summary It has been estimated that 145,600 people were diagnosed with colorectal cancer (CRC) and 51,020 deaths were predicted due to this disease in 2019 (https://seer.can...

$4.02M
USD
Completed NON-SBIR/STTR RPGS
MYC-regulated RNA Binding Protein Networks and Spliced Isoforms Driving Cancer
NATIONAL CANCER INSTITUTE Jackson Laboratory United States 2021 – 2026

SUMMARY Alternative RNA splicing is a key step in gene expression regulation and contributes to transcriptional diversity by selecting which transcript isoforms are produced in a s...

$5.33M
USD
Completed OTHER RESEARCH-RELATED
Functional epigenomics of transgenic cellular immunotherapies for cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Cancer immunotherapy with T-cells expressing a transgenic T-cell receptor (TCR) can generate sustained clinical responses in a variety of malignancies. How...

$1.82M
USD
Completed NON-SBIR/STTR RPGS
Quantitative top-down proteomics of human colorectal cancer cells and tumors
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2026

Project Summary It has been estimated that 145,600 people were diagnosed with colorectal cancer (CRC) and 51,020 deaths were predicted due to this disease in 2019 (https://seer.can...

$3.63M
USD